Kezar Life Sciences, Inc. (Nasdaq: KZR), the stock soared 17.65% to $6.5 in the after-hours session following the biotechnology firm disclosed that it was added to the NASDAQ Biotech Index (Nasdaq: NBI), effective before market opening on Monday 21 December 2020.
The NASDAQ Biotechnology Index is intended to measure stocks’ success traded on the Nasdaq Stock Exchange (Nasdaq), categorized under the Industry Classification Benchmark as either biotechnology or pharmaceutical (ICB). Under an updated capitalization-weighted algorithm, the NASDAQ Biotechnology Index is calculated.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
NASDAQ Biotechnology Index firms must meet eligibility rules, including minimum market capitalization, estimated daily trading volume and, among other factors, seasoning as a public company. In December, Nasdaq selects constituents once per annum. For more information about the NASDAQ.